Business Context and Reporting Period
This Form 8-K Current Report was filed by NEOGENOMICS INC on August 5, 2025. The filing addresses a corporate governance event involving the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure regarding a director's resignation and contains no financial performance data.
Material Changes
Board of Director Resignation: On August 5, 2025, Elizabeth Floegel resigned from the Board of Directors, effective immediately. The Company stated that the resignation did not result from any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or new risk factors. The only disclosed contingency is the immediate vacancy on the Board of Directors.
Key Facts for Investor Verification
- Elizabeth Floegel resigned from the Board of Directors effective August 5, 2025.
- The resignation was not caused by any disagreement with the Company.
- The filing was signed by Alicia C. Olivo, EVP, General Counsel & Business Development and Corporate Secretary, on August 8, 2025.
- No financial results or operational metrics are included in this specific filing.